Dimethyl fumarate
disease-modifying treatment for multiple sclerosis
Nothing to addWhat this medicine is for
Pharmacologically, Dimethyl fumarate relates to the category “disease-modifying treatment for multiple sclerosis”. This disease-modifying treatment modulates the immune system to space out multiple sclerosis flare-ups.
In the case of Dimethyl fumarate, this means: Treats multiple sclerosis. It is generally taken over the long term, within regular monitoring, and is not stopped on your own initiative.
Under which brands it is found
In France, about 10 reimbursable presentations containing Dimethyl fumarate are recorded. It comes under various trade names and in generic form.
- Dimethyl Fumarate Accord
- Dimethyl Fumarate Arrow
- Dimethyl Fumarate Biogaran
- Dimethyl Fumarate Eg
- Dimethyl Fumarate Eg Labo
- Dimethyl Fumarate Mylan
- Dimethyl Fumarate Sandoz
- Dimethyl Fumarate Teva Sante
- and other presentations
Generics and the original brand are equivalent for the active substance; only the appearance, the name or the excipients may differ.
Do you need a supplement? No.
We put forward no supplement for Dimethyl fumarate: that would be forcing a need that does not exist. The great majority of medicines call for no particular supplementation, and acknowledging this is part of the way we work. We design a supplement only where the data support it, across five specific classes.
Talk about it in the community
A space to share among people who are affected: the early days, the habits built up over the years, what each person has found to live better with it. Shared experiences, nothing medical.
Related molecules
To explore in the « Neurology and mind » family and its neighbours.
See the whole « Neurology and mind » family · Back to the atlas